Jennifer Peters
Family Medicine · Kingsport, TNNPI 1578640561
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 288 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 23.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,654 and has fallen 94.0% since, to $99 in 2024.
Across 288 payments — averaging $13.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$917
- GSK$499
- AbbVie$308
- Lilly USA, LLC$286
- AstraZeneca$225
- Novartis$165
- plus $2K from 29 others
What the payments were for
- Food & beverage$3,965100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 73 | $917 |
| GSK | 37 | $499 |
| AbbVie(2 entities) | 24 | $308 |
| Lilly USA, LLC | 26 | $286 |
| AstraZeneca | 16 | $225 |
| Novartis | 12 | $165 |
| Pfizer | 13 | $164 |
| Amgen(2 entities) | 10 | $153 |
| Kowa Pharmaceuticals America, Inc. | 7 | $111 |
| Medline Industries LP | 1 | $99 |
| Amarin Pharma, Inc. | 5 | $94 |
| Sanofi-aventis U.S. LLC | 7 | $91 |
| Johnson & Johnson | 7 | $90 |
| Sunovion Pharmaceuticals Inc. | 6 | $86 |
| Astellas Pharma US Inc | 4 | $86 |
| Boehringer Ingelheim | 6 | $80 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $79 |
| Otsuka America Pharmaceutical, Inc. | 3 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $55 |
| Merck | 3 | $36 |
| Bayer | 2 | $30 |
| Acadia Pharmaceuticals Inc | 2 | $28 |
| Mylan Specialty L.p. | 2 | $24 |
| Biohaven Pharmaceuticals, Inc. | 2 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| Kyowa Kirin, Inc. | 1 | $23 |
| Avanir Pharmaceuticals, Inc. | 1 | $17 |
| UCB, Inc. | 1 | $17 |
| Shire North American Group Inc | 1 | $14 |
| Circassia Inc. | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $13 |
| Dexcom, Inc. | 1 | $13 |
| Eisai Inc. | 1 | $12 |
| Sanofi Pasteur Inc. | 1 | $12 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
How this compares
$3,965 in reported general payments places this provider in the 80th percentile of 2,087 family medicine providers in Tennessee.
Other family medicine in Kingsport
- Curtis JantziKingsport$39K
- Warren JonesKingsport$27K
- Emily HubbsKingsport$19K
- Shelton HagerKingsport$14K
- Kevin DennisFranklin$354K
- Charolette JacksonBartlett$162K
- Keren HolmesNashville$58K
- Kabir Harricharan SinghNewport$49K
- Khaisha GistAntioch$49K
- Jerry PunchKnoxville$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.